Invention Grant
- Patent Title: Pyridazinones
- Patent Title (中): 哒嗪酮
-
Application No.: US12626982Application Date: 2009-11-30
-
Publication No.: US08178538B2Publication Date: 2012-05-15
- Inventor: Daniela Alberati , Luca Gobbi , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Rosa Maria Rodriguez-Sarmiento , Mark Rogers-Evans , Markus Rudolph
- Applicant: Daniela Alberati , Luca Gobbi , Matthias Koerner , Bernd Kuhn , Jens-Uwe Peters , Rosa Maria Rodriguez-Sarmiento , Mark Rogers-Evans , Markus Rudolph
- Applicant Address: US NJ Nutley
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Nutley
- Agent George W. Johnston; Patricia S. Rocha-Tramaloni; Kimberly J. Prior
- Priority: EP08170716 20081204
- Main IPC: A61K31/501
- IPC: A61K31/501 ; C07D403/04
Abstract:
The present invention is concerned with novel pyridazinones of formula (I) wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used for the treatment of CNS disorders.
Public/Granted literature
- US20100152193A1 PYRIDAZINONES Public/Granted day:2010-06-17
Information query
IPC分类:
